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 The varied outcomes of clinical trials of cognitive behaviour therapy for psychosis 
(CBTp) have recently been reported, with the methodological rigour of the individual studies 
being associated with outcome [1]. However, issues relating to trial therapists training, 
experience and supervision may also be predictive of outcome. The aim of the current study 
is to report on a number of therapist effects within clinical trials of CBTp, and their 
relationship with outcome. Such dissection of the evidence base for CBTp is clearly 
important in helping to develop future training guidelines for evidence based interventions. 
The current report builds upon our recently published meta-analysis of CBTp [1], which 
included 34 trials of CBTp and reported a moderate effect size (approximately 0.4) for a 
variety of outcome measures, e.g. positive symptoms, negative symptoms and functioning. In 
order to reduce potential heterogeneity, we limited our current sample to include only those 
studies based on individual CBTp targeting positive symptoms, which form the vast majority 
of our current evidence base. We include a measure of trial methodology, the Clinical Trials 
Assessment Measure (CTAM) [2], in order to enable this variable to be included within 
analyses.  
Given the lack of previous research upon which to base current hypotheses, we 
generated a list of 8 variables associated with training and supervision. 18 international 
experts, drawn from the Beck CBT for psychosis group, rated all 8 variables as important 
factors within clinical trials of CBTp. We re-ran the search criteria employed by Wykes et al. 
(2008), using the same entry criteria, to ensure our sample was up to date. Data for the main 
study were gathered by contacting the lead authors of the selected trials in order to obtain the 
relevant information for each trial. One study [3] was dropped from the current analyses, as 
data on training and supervision of trial therapists were not available, and one new study was 
included [4], leaving a final sample of 24 studies.  
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The extraction of data relating to positive symptoms and the calculation of individual trial 
effect size was conducted as in our previous study [1]. We conducted an initial analyses 
which consisted of correlations between the 8 therapist and supervision variables, along with 
the participant characteristics of age, gender and number of hospitalisations, and effect size.  
We then assessed the predictive power of these variables on effect size in separate linear 
meta-regressions. Given that methodology has been shown to be a potent variable in relation 
to outcome [1]
 
we investigated these within trial effects whilst controlling for methodological 
rigour.  
Almost 70% of the combined caseload from all 24 trials was conducted by a therapist 
without a specific postgraduate qualification in CBT. About two-thirds of the overall 
caseload was conducted by clinical psychologists, with 13 of the 24 trials employing this 
profession alone. On average trial therapists received more than 4 hours of supervision per 
month, predominantly on an individual basis. Thirty-seven percent of the overall participants 
were seen by a therapist who was focussing their clinical work exclusively on a clinical trial. 
There was a significant positive effect of the proportion of  trial therapists clinical 
work which was exclusively focussed on trial cases, and an almost significant positive effect 
of the quantity supervision therapists received within a trial, on effect size after controlling 
for CTAM scores (see Table 1). The correlation coefficients of both these variables were 
above 0.4 and significant. They were not significantly correlated with each other (r=0.22; 
p=0.3). All other correlations were 0.31 or smaller and non-significant.  
                                                          ----------------------- 
INSERT TABLE 1 ABOUT HERE 
----------------------- 
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Our results suggest that therapists whose clinical work was predominantly focussed 
on a clinical trial achieved better outcomes. Clearly, the amount of clinical work dedicated to 
a clinical trial will be associated with other variables. However, a major strength of the 
current analyses was that it enabled overall trial methodology to be controlled for, suggesting 
that this is not the mediating variable. It is therefore seems that being able to focus on trial 
clinical work is associated with something that is yet to be measured, such as the 
development of specific skills which are not gained through generic clinical experience. 
Although there is much to learn within this area, it would seem important for clinicians to 
note that the best clinical outcomes are associated with those who dedicate most of their 
clinical work to a specific intervention. This may especially be the case within such a 
complex intervention as CBT for psychosis. Therefore, whilst it is important that clinicians 
receive appropriate training they also appear to need a reasonably high caseload in order to 
maintain best practice. 
There was some support for more frequent supervision of trial therapists being 
associated with improved outcome, although a metaregression of the same relationship 
showed a result slightly outside of significance. While more frequent supervision may have 
occurred within the larger trials with more funds, the quality of trial methodology was 
controlled within the regression analyses, suggesting supervision frequency is likely to be an 
independent predictor of outcome. Further, the frequency of supervision was not related to 
the percentage of therapists’ clinical work dedicated to a clinical trial, and these variables are 
therefore likely to have an independent effect on outcome. Our results highlight the need for 
further research in order to ‘unpack’ which therapist training and supervision characteristics 
are of significance in order to efficiently disseminate the protocols produced within clinical 
trials. In the meantime we suggest that when clinical trials of psychological interventions are 
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published that the supervision arrangements should be detailed along with whether therapists 
were trial dedicated or not. 
These results  need to be treated in the context of multiple tests having been 
performed. Also, the limited variance within some of the variables included within the 
current study, and a moderate sample size of 24 only provides power to detect large effects. 
However, if effects are subtle they may not be important. However,  there is need for caution 
when interpreting non-significant results.  
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Table 1. Summary of correlation and meta-regression analyses of effect size against 3 
demographic and 8 therapist and supervision variables while controlling for CTAM scores. 
(N=24) 
  
 
Correlation 
 
 
P 
 
Meta-Regression 
coefficient (95 % 
Confidence 
intervals) 
 
 
T 
 
 
P 
 
Partial 
r 
 
Participant Characteristics 
 
Mean Age 
 
0.18 
 
0.41 
0.0002 
(-0.024, -0.024) 
 
0.02 
 
0.99 
 
-0.003 
 
Gender (% male)  
(N=23) 
 
-0.23 
 
0.30 
 
-0.415 
(-1.996, 1.166) 
 
-0.59 
 
0.53 
 
-0.12 
 
Number of 
Hospitalisations 
(N=14) 
 
0.07 
 
0.81 
 
-0.077 
(-0.255, 0.100) 
 
-0.96 
 
0.36 
 
-0.33 
 
Therapist Characteristics 
Having a postgraduate 
CBT qualification 
 
-0.04 
 
0.84 
 
-0.063 
(-0.411, 0.284) 
 
-0.38 
 
0.71 
 
-0.08 
Number of years of 
experience in CBT for 
psychosis 
 
-0.31 
 
0.15 
 
-.018 
(-0.093, 0.058) 
 
-0.49 
 
0.63 
 
-0.10 
Number of years of 
generic clinical 
experience 
 
-0.31 
 
0.15 
 
-0.015 
(-0.051, -0.022) 
 
-0.85 
 
0.40 
 
-0.18 
Type of core profession 
(% clin psych) 
 
-0.01 
 
0.98 
 
0.032 
(-0.234, 0.299) 
 
0.25 
 
 
0.80 
 
 
0.05 
Quantity of supervision 
during the trial 
 
0.45 
 
0.03 
 
0.032 
(-0.001, 0.0646) 
 
2.03 
 
0.056 
 
0.40 
Supervision as group or 
individual (% individual) 
 
-0.31 
 
0.15 
 
-0.193 
(-0.442, – 0.056) 
 
-1.61 
 
0.12 
 
-0.33 
Quantity of training in 
trial protocol before trial 
onset 
 
-0.11 
 
0.63 
 
-0.001 
(-0.01, 0.007) 
 
-0.27 
 
0.79 
 
-0.06 
Proportion of therapists 
work which is focussed 
purely on the trial 
 
0.43 
 
0.04 
 
0.332 
(0.008, 0.656) 
 
2.13 
 
0.045 
 
0.38 
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